Technology Platform Nutraceutical Development BM-A1 Clinical Trial Therapeutic Development Publications

Products BioMarker intends to offer evaluation service products based on individual genomic and proteomic testing, including: Individual profile assessments – providing an individual comparison to demonstrated biomarkers of aging; and Intervention assessment, monitoring and prediction – providing real-time feedback of individual responses to interventions, again in comparison to demonstrated biomarkers of aging. These service products are expected to be available in the near future, pending our continued evaluation and validation. As development concludes, we will publish updated product descriptions on our Product pages. BioMarker's unique approach is protected by several patents, issued and pending, including the first issued U.S. patent in the field: Interventions to mimic the effects of calorie restriction, US Patent 6,406,853, June 18, 2002.